In a clinical trial evaluating hematopoietic stem cell transplantation to treat T1D, patients that required lower exogenous insulin saw increased TGF-β and IL-10 immunoregulatory and decreased IFN-γ, IL-2 inflammatory cytokines (120). Here, INS is linked to type 1 diabetes mellitus.